Literature DB >> 19808421

Therapeutic strategies for long-QT syndrome: does the molecular substrate matter?

Yanfei Ruan1, Nian Liu, Carlo Napolitano, Silvia G Priori.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 19808421     DOI： 10.1161/CIRCEP.108.795617

Source DB:  PubMed          Journal:  Circ Arrhythm Electrophysiol        ISSN： 1941-3084


× No keyword cloud information.
  21 in total

1.  Evaluation of a new high-throughput next-generation sequencing method based on a custom AmpliSeq™ library and ion torrent PGM™ sequencing for the rapid detection of genetic variations in long QT syndrome.

Authors:  Gilles Millat; Valérie Chanavat; Robert Rousson
Journal:  Mol Diagn Ther       Date:  2014-10       Impact factor: 4.074

2.  Dynamic partnership between KCNQ1 and KCNE1 and influence on cardiac IKs current amplitude by KCNE2.

Authors:  Min Jiang; Xulin Xu; Yuhong Wang; Futoshi Toyoda; Xian-Sheng Liu; Mei Zhang; Richard B Robinson; Gea-Ny Tseng
Journal:  J Biol Chem       Date:  2009-04-16       Impact factor: 5.157

Review 3.  Emerging concepts in the pharmacogenomics of arrhythmias: ion channel trafficking.

Authors:  William T Harkcom; Geoffrey W Abbott
Journal:  Expert Rev Cardiovasc Ther       Date:  2010-08

Review 4.  Genetics of congenital and drug-induced long QT syndromes: current evidence and future research perspectives.

Authors:  Saagar Mahida; Andrew J Hogarth; Campbell Cowan; Muzahir H Tayebjee; Lee N Graham; Christopher B Pepper
Journal:  J Interv Card Electrophysiol       Date:  2013-03-21       Impact factor: 1.900

5.  Light phase-restricted feeding slows basal heart rate to exaggerate the type-3 long QT syndrome phenotype in mice.

Authors:  Elizabeth A Schroder; Don E Burgess; Cody L Manning; Yihua Zhao; Arthur J Moss; Abhijit Patwardhan; Claude S Elayi; Karyn A Esser; Brian P Delisle
Journal:  Am J Physiol Heart Circ Physiol       Date:  2014-10-24       Impact factor: 4.733

6.  Epidemiologic, molecular, and functional evidence suggest A572D-SCN5A should not be considered an independent LQT3-susceptibility mutation.

Authors:  David J Tester; Carmen Valdivia; Carole Harris-Kerr; Marielle Alders; Benjamin A Salisbury; Arthur A M Wilde; Jonathan C Makielski; Michael J Ackerman
Journal:  Heart Rhythm       Date:  2010-04-24       Impact factor: 6.343

7.  High-risk long QT syndrome mutations in the Kv7.1 (KCNQ1) pore disrupt the molecular basis for rapid K(+) permeation.

Authors:  Don E Burgess; Daniel C Bartos; Allison R Reloj; Kenneth S Campbell; Jonathan N Johnson; David J Tester; Michael J Ackerman; Véronique Fressart; Isabelle Denjoy; Pascale Guicheney; Arthur J Moss; Seiko Ohno; Minoru Horie; Brian P Delisle
Journal:  Biochemistry       Date:  2012-11-02       Impact factor: 3.162

Review 8.  [Long QT syndrome. History, genetics, clinical symptoms, causes and therapy].

Authors:  T Krönauer; P Friederich
Journal:  Anaesthesist       Date:  2015-08       Impact factor: 1.041

9.  A KCNQ1 mutation causes a high penetrance for familial atrial fibrillation.

Authors:  Daniel C Bartos; Jeffrey B Anderson; Rachel Bastiaenen; Jonathan N Johnson; Michael H Gollob; David J Tester; Don E Burgess; Tessa Homfray; Elijah R Behr; Michael J Ackerman; Pascale Guicheney; Brian P Delisle
Journal:  J Cardiovasc Electrophysiol       Date:  2013-01-25

10.  Semiconductor Whole Exome Sequencing for the Identification of Genetic Variants in Colombian Patients Clinically Diagnosed with Long QT Syndrome.

Authors:  Mariana Burgos; Alvaro Arenas; Rodrigo Cabrera
Journal:  Mol Diagn Ther       Date:  2016-08       Impact factor: 4.074
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.